The invention relates to polypeptides referred to herein as obestatin. Obestatin, analogs and mimetics thereof act in signaling pathways, and are shown to modulate hypertension and other cardiovascular parameters, and gastric emptying.

 
Web www.patentalert.com

< Subtilases and subtilase variants having altered immunogenicity

< Lipolytic enzyme variant

> Substituted fused heterocyclic C-glycosides

> Avermectin b1 monosaccharide derivatives
~ 00294